ONCY
Price
$1.21
Change
-$0.06 (-4.72%)
Updated
Jul 21 closing price
Capitalization
116.05M
15 days until earnings call
PROK
Price
$3.22
Change
+$0.07 (+2.22%)
Updated
Jul 21 closing price
Capitalization
429.61M
16 days until earnings call
Interact to see
Advertisement

ONCY vs PROK

Header iconONCY vs PROK Comparison
Open Charts ONCY vs PROKBanner chart's image
Oncolytics Biotech
Price$1.21
Change-$0.06 (-4.72%)
Volume$887.1K
Capitalization116.05M
ProKidney
Price$3.22
Change+$0.07 (+2.22%)
Volume$3.98M
Capitalization429.61M
ONCY vs PROK Comparison Chart in %
Loading...
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ONCY vs. PROK commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONCY is a StrongBuy and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (ONCY: $1.21 vs. PROK: $3.22)
Brand notoriety: ONCY and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ONCY: 64% vs. PROK: 22%
Market capitalization -- ONCY: $116.05M vs. PROK: $429.61M
ONCY [@Biotechnology] is valued at $116.05M. PROK’s [@Biotechnology] market capitalization is $429.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ONCY’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • ONCY’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, both ONCY and PROK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ONCY’s TA Score shows that 3 TA indicator(s) are bullish while PROK’s TA Score has 7 bullish TA indicator(s).

  • ONCY’s TA Score: 3 bullish, 3 bearish.
  • PROK’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, PROK is a better buy in the short-term than ONCY.

Price Growth

ONCY (@Biotechnology) experienced а +0.83% price change this week, while PROK (@Biotechnology) price change was -12.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.37%. For the same industry, the average monthly price growth was +15.66%, and the average quarterly price growth was +33.77%.

Reported Earning Dates

ONCY is expected to report earnings on Nov 12, 2025.

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($430M) has a higher market cap than ONCY($116M). PROK YTD gains are higher at: 90.533 vs. ONCY (32.414). ONCY has higher annual earnings (EBITDA): -32.86M vs. PROK (-160.12M). PROK has more cash in the bank: 328M vs. ONCY (15.3M). ONCY has less debt than PROK: ONCY (1M) vs PROK (3.37M). PROK has higher revenues than ONCY: PROK (306K) vs ONCY (0).
ONCYPROKONCY / PROK
Capitalization116M430M27%
EBITDA-32.86M-160.12M21%
Gain YTD32.41490.53336%
P/E RatioN/AN/A-
Revenue0306K-
Total Cash15.3M328M5%
Total Debt1M3.37M30%
FUNDAMENTALS RATINGS
ONCY: Fundamental Ratings
ONCY
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ONCYPROK
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
65%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 9 days ago
75%
Bullish Trend 13 days ago
72%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
70%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 5 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMPNY14.690.24
+1.66%
Sompo Hldgs Inc
FFDF35.38N/A
N/A
FFD Financial Corp.
CUCSF0.59N/A
N/A
China Communications Services Corp., Ltd.
KARX0.55N/A
N/A
Karbon-X Corp.
CYDY0.30-0.02
-4.94%
CytoDyn Inc.

ONCY and

Correlation & Price change

A.I.dvisor tells us that ONCY and ABCL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ONCY and ABCL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCY
1D Price
Change %
ONCY100%
-4.72%
ABCL - ONCY
31%
Poorly correlated
+14.96%
SRRK - ONCY
31%
Poorly correlated
+0.98%
RXRX - ONCY
27%
Poorly correlated
+9.59%
VCYT - ONCY
27%
Poorly correlated
-2.04%
PROK - ONCY
26%
Poorly correlated
+2.22%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with LGVN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then LGVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+2.22%
LGVN - PROK
40%
Loosely correlated
+10.53%
NRIX - PROK
39%
Loosely correlated
+0.36%
APGE - PROK
38%
Loosely correlated
-0.51%
CGEM - PROK
37%
Loosely correlated
-0.13%
KYMR - PROK
37%
Loosely correlated
-2.25%
More